New treatment options for melanoma are being described as the global gold standard.
Pharmac's proposing to increase access to nivolumab and ipilimumab for treating stage 3b and 4 melanoma, from May.
Pre-surgery use of the immunotherapy drugs can lower the chance of cancer returning.
Medical oncologist Dr Gareth Rivalland told Ryan Bridge it's state of the art treatment.
He says it's the best combination and will kill off the cancer in 60% of people.
LISTEN ABOVE

Laura McClure: ACT Education Spokesperson on the Government backing down from changing homeschool laws
02:47

Nick Tuffley: ASB Chief Economist on the Reserve Bank's decision to hold the OCR at 2.25%
03:15

Simon Bridges: Auckland Business Chamber CEO on his expectations for Budget 2026
03:20